Form 4 for TXG 10x Genomics, Inc.
Accepted 2022-01-04 00:00:00 ET · period of report 2021-12-30 · accession 0001567619-22-000366 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-04 | 2021-12-30 | TXG | STUELPNAGEL JOHN R | Dir | S - Sale | $150.92 | -5,000 | 341.6K | -1% | -$754.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-30 | S | D | 3,218 | $150.56 | 343,398 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-12-30 | S | D | 1,782 | $151.57 | 341,616 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $151.02 to $151.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |